EUCTR2013-004276-35-ES进行中（未招募）不适用
Phase II, Double-blind, randomized, 1-way cross-over, to investigate the effectiveness of the combination of ascorbic acid (vitamin C) and tocopherol (vitamin E) versus placebo for the treatment of depressive disorders in elderly
Hospital Regional Universitario. IBIMA0 个研究点开始时间: 2014年6月9日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Diagnosis of mild depression smaller or larger by Mini International Neuropsychiatric Interview (MINI).
- •Having more than 55 years old
- •Have signed the informed consent document before you start participating in the trial.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 25
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 25
排除标准
- •Individuals with other psychiatric diagnosis as the first diagnosis.
- •To have suffered serious medical problems in the last 12 months.
- •Are taking more than 100mg of vitamin E or C a day in the last 4 months.
- •Having physical, mental or sensory problems that prevent the assessment of effectiveness.
- •Hypersensitivity to any component of the preparation.
- •Previous pathology of kidney stones
研究者
相似试验
尚未招募
2 期
Phase 2, randomized, double-blind, two-way crossover, placebo-controlled clinical trial of the efficacy and safety of Mucuna pruriens seed extract in men with mild and mild to moderate erectile dysfunctioErectile dysfunctionMucuna pruriens var. pruriensIIEF-5Cross-over studyTCTR20240605002Faculty of Medicine, Chiang Mai University12
进行中（未招募）
1 期
A Phase II, double-blind, randomized, cross-over, international,multicentre study to evaluate the analgesic efficacy of 3 weeks oraladministration of AZD4282 300 mg b.i.d. compared with placebo inposttraumatic neuralgiaDiagnostic of Post Traumatic NeuralgiaEUCTR2004-004907-39-DKAstraZeneca AB60
进行中（未招募）
1 期
A Phase II, double-blind, randomized, cross-over, international,multicentre study to evaluate the analgesic efficacy of 3 weeks oraladministration of AZD4282 300 mg b.i.d. compared with placebo inpostherpetic neuralgiaDiagnosis of postherpetic neuralgiaEUCTR2004-004908-21-DKAstraZeneca AB60
进行中（未招募）
不适用
A phase IIa, double-blind, randomized, 2-way cross-over study to evaluate the effect of a single dose of AZD1386 95 mg compared to placebo in a multimodal experimental pain model on esophageal sensitivity in GERD patients with a partial response to PPI treatment - naGastroesophageal Reflux Disease (GERD) is the intended indicationMedDRA version: 9.1Level: LLTClassification code 10017924Term: Gastroesophageal refluxEUCTR2008-007420-26-DKAstraZeneca AB30
进行中（未招募）
不适用
A phase IIa, double-blind, randomized, 2-way cross-over study to evaluate the effect of a single dose of AZD1386 95 mg compared to placebo in a multimodal experimental pain model on esophageal sensitivity in GERD patients with a partial response to PPI treatment - naEUCTR2008-007420-26-SEAstraZeneca AB30